SYMIC BIOMEDICAL
Symic Biomedical is a developer of matrix regulator therapeutics designed to affect matrix degradation and structure. The company's therapeutics bind to targets in the matrix, damaged in response to injury or because of disease, to inhibit pathological inflammatory responses, enabling clinicians to investigate applications in the areas of fibrosis, oncology and diseases of the central nervous system.
SYMIC BIOMEDICAL
Industry:
Biotechnology Business Intelligence Health Care
Founded:
2012-01-01
Address:
Emeryville, California, United States
Country:
United States
Website Url:
http://www.symic.bio
Total Employee:
1+
Status:
Active
Contact:
1(415) 805-9005
Email Addresses:
[email protected]
Total Funding:
84.15 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Mailgun 1and1
Similar Organizations
BALX Holdings
Balx Holdings operates in the healthcare industry focusing on biotechnology business.
Ixcela
Ixcela operates in the healthcare industry focusing on biotechnology business.
Duo Xi Yue Mu Ying Yue Zi Hui Suo
Duo Xi Yue Mu Ying Yue Zi Hui Suo provides scientific, healthy and cost-effective one-stop confinement services for confinement moms.
Gradient Pharmaceuticals
The healthcare industry focusing on biotechnology business.
living platform
living platform is Management of nursing care business and services business group companies for persons with disabilities.
Mitokinin
Mitokinin is operates in the healthcare industry focusing on biotechnology business.
Orionis Biosciences
Orionis Biosciences operates in the healthcare industry focusing on biotechnology business & innovation.
Patara Pharma
Patara Pharma operates in the healthcare industry focusing on the biotechnology business.
Skipta
Social network of specialized online medical communities for verified healthcare professionals
Tetherex Pharmaceuticals
Tetherex Pharmaceuticals operates in the healthcare industry focusing on biotechnology business.
Current Employees Featured
Founder
Investors List
Cell Innovation Partners
Cell Innovation Partners investment in Series C - Symic Biomedical
ReproCELL
ReproCELL investment in Series C - Symic Biomedical
Shinsei Bank
Shinsei Bank investment in Series C - Symic Biomedical
Mission BioCapital
Mission BioCapital investment in Series B - Symic Biomedical
Alex Popa
Alex Popa investment in Series B - Symic Biomedical
HEDA Ventures
HEDA Ventures investment in Series B - Symic Biomedical
Lilly Ventures
Lilly Ventures investment in Series A - Symic Biomedical
National Institutes of Health
National Institutes of Health investment in Grant - Symic Biomedical
Lilly Ventures
Lilly Ventures investment in Series A - Symic Biomedical
Mitsui Global Investment
Mitsui Global Investment investment in Series A - Symic Biomedical
Official Site Inspections
http://www.symic.bio
- Host name: 216.24.57.1
- IP address: 216.24.57.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Symic Biomedical"
Symic Bio Company Profile 2024: Valuation, Funding & Investors
Symic Bio General Information Description. Developer of a matrix regulator therapeutics technology designed to affect matrix degradation and structure. The company's technology …See details»
Symic Biomedical - Crunchbase Company Profile & Funding
Symic Biomedical is a developer of matrix regulator therapeutics designed to affect matrix degradation and structure. The company's therapeutics bind to targets in the matrix, damaged …See details»
Symic Bio Company Profile - Office Locations, Competitors ... - Craft
Apr 25, 2019 Symic Bio has 5 employees at their 1 location and $82.38 m in total funding,. See insights on Symic Bio including office locations, competitors, revenue, financials, executives, …See details»
Symic Bio - LinkedIn
Symic Bio is developing a new category of therapeutics that offer an exciting and biologically innovative approach to treating disease. While it is clear that cells play an important role in ...See details»
Symic Biomedical Company Profile | Management and Employees …
Symic Bio currently has two clinical candidates: SB-0 61, directed at disease modification and pain management in the treatment of osteoarthritis, and SB-030, targeting the prevention of …See details»
Symic Bio | Stanford Mussallem Center for Biodesign
He co-founded Symic Bio in 2012 and served as the company’s Vice President of Operations until 2019. To learn more, visit the Symic Bio website. Disclaimer of Endorsement: All references to specific products, companies, or services, …See details»
Symic Bio - Products, Competitors, Financials, Employees, …
When was Symic Bio founded? Symic Bio was founded in 2012. Where is Symic Bio's headquarters? Symic Bio's headquarters is located at 1400 Pine Street, #640505, San …See details»
Symic | VentureRadar
Symic Bio is a biopharmaceutical company developing a new category of therapeutics focused on matrix biology. The (extracellular) matrix is the non-cellular component of the body’s tissues …See details»
Symic Bio
Copyright © 2023 Symic Bio, Inc.See details»
Symic - VentureRadar
Symic biomedical, inc. USA Privately Held Symic Biomedical is developing a new category of therapeutics that offer an exciting and biologically innovative approach to treating disease. …See details»
Symic Bio, Inc. Company Profile | Emeryville, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Symic Bio, Inc. of Emeryville, CA. Get the latest business insights from Dun & Bradstreet.See details»
Symic Biomedical - Overview, News & Similar companies - ZoomInfo
Nov 30, 2015 Symic Bio currently has two clinical candidates: SB-061, directed at disease modification and pain management in the treatment of osteoarthritis, and SB-030, targeting the …See details»
Symic Bio - Org Chart, Teams, Culture & Jobs - The Org
View Symic Bio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Symic Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Symic Bio currently has two clinical candidates: SB-061, directed at disease modification and pain management in the treatment of osteoarthritis, and SB-030, targeting the prevention of …See details»
Symic Bio - Org chart - The Org
Explore Symic Bio's organizational chart. Discover current team members including executives, board members, and advisors.See details»
Symic Biomedical - Company Profile - Tracxn
Nov 27, 2024 Symic Bio Announces Results of Locally-Administered Therapeutic SB-030 in Preclinical Model of Vascular Interventionpipelinereview.com • Mar 06, 2018 • Symic …See details»
Symic Bio » News
Jan 22, 2021 Symic Bio Selected for “The Best of The Liver Meeting 2018” at AASLD. Posted on November 9, 2018. Symic Bio, a biopharmaceutical company developing novel extracellular …See details»
Ken Horne - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Previously, Mr. Horne was …See details»
SB-061 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 Symic Bio currently has two clinical candidates: SB-061, directed at disease modification and pain management in the treatment of osteoarthritis, and SB-030, targeting the …See details»
Symic Bio » Osteoarthritis
SB-061 from Symic Bio SB-061, a therapeutic bioconjugate molecule inspired by the properties of aggrecan, is a drug delivered directly to the joint via intra-articular injection. SB-061 directly …See details»